Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine

被引:15
作者
Tzovaras, Vasilis [1 ]
Tsimihodimos, Vasilis [1 ]
Kostara, Christina
Mitrogianni, Zoi [1 ]
Elisaf, Moses [1 ]
机构
[1] Univ Ioannina, Sch Med, Dept Internal Med, GR-45110 Ioannina, Greece
关键词
aminoglycosides; proton nuclear magnetic resonance spectroscopy; tubular dysfunction; CALCIUM-SENSING RECEPTOR; FRACTIONAL EXCRETION; NMR-SPECTROSCOPY; CELL-DEATH; GENTAMICIN; RAT; HYPOMAGNESEMIA; ELECTROLYTE; METABOLITES; DISORDERS;
D O I
10.1093/ndt/gfr074
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Acute kidney injury is a relatively common complication of aminoglycoside therapy that affects 10-20% of patients receiving antibiotics of this class. Although the vast majority of patients do recover, the presence of certain risk factors may alter the clinical presentation and result in permanent renal damage. Thus, aminoglycoside-induced nephrotoxicity is a major concern and early diagnosis is critical. The aim of the present study was to characterize the early stages of aminoglycoside-induced nephrotoxicity using proton nuclear magnetic resonance ((1)H NMR) spectroscopy of urine. Methods. We studied 19 previously healthy patients who were hospitalized in our clinic due to bacterial infections. Combined antibiotic treatment with amikacin (1 g once daily) and a beta-lactam antibiotic was instituted in all patients. Urine and blood samples were collected before and after 5 days of aminoglycoside treatment. Results. (1)H NMR spectroscopic data showed increased amounts of alanine and lactic acid (+138 and +255% compared to baseline values, respectively) and decreased hippurate (-50%) after aminoglycoside treatment. In addition, fractional excretions of sodium, magnesium and calcium were significantly increased (+271, +295 and +60%, respectively). These findings indicate that aminoglycosides can affect nephron tubules through two unrelated mechanisms that produce a partial 'Fanconi-like syndrome' and a 'Bartter-like syndrome'. However, because none of the study participants developed renal failure, these alterations are probably reversible and should not be used as sensitive or specific indicators of impending renal insufficiency. Conclusions. Our study findings confirm that aminoglycosides can induce both proximal and distal renal tubular dysfunction. However, it remains unclear whether the early functional changes detected by (1)H NMR spectroscopy in patients treated with aminoglycosides are of prognostic value.
引用
收藏
页码:3219 / 3223
页数:5
相关论文
共 34 条
[1]  
ELISAF M, 1995, POSTGRAD MED J, V71, P211, DOI 10.1136/pgmj.71.834.211
[2]  
Elisaf M, 1997, MAGNESIUM RES, V10, P315
[3]   Effectiveness and safety of once-daily aminoglycosides: A meta-analysis [J].
FerriolsLisart, R ;
AlosAlminana, M .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (10) :1141-1150
[4]  
FOSTER JE, 1992, J PHARMACOL EXP THER, V261, P38
[5]  
GARTLAND KPR, 1989, MOL PHARMACOL, V35, P242
[6]   Calcium-sensing receptor antagonism or lithium treatment ameliorates aminoglycoside-induced cell death in renal epithelial cells [J].
Gibbons, Claire E. ;
Maldonado-Perez, David ;
Shah, Amish N. ;
Riccardi, Daniela ;
Ward, Donald T. .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2008, 1782 (03) :188-195
[7]   Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury [J].
Hauet, T ;
Baumert, H ;
Gibelin, H ;
Hameury, F ;
Goujon, JM ;
Carretier, M ;
Eugene, M .
CRYOBIOLOGY, 2000, 41 (04) :280-291
[8]  
Kelepouris E, 1998, SEMIN NEPHROL, V18, P58
[9]   AMINOGLYCOSIDE-INDUCED RENAL PHOSPHOLIPIDOSIS AND NEPHROTOXICITY [J].
LAURENT, G ;
KISHORE, BK ;
TULKENS, PM .
BIOCHEMICAL PHARMACOLOGY, 1990, 40 (11) :2383-2392
[10]   Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine [J].
Le Moyec, L ;
Racine, S ;
Le Toumelin, P ;
Adnet, F ;
Larue, V ;
Cohen, Y ;
Leroux, Y ;
Cupa, M ;
Hantz, E .
CRITICAL CARE MEDICINE, 2002, 30 (06) :1242-1245